<DOC>
	<DOCNO>NCT01469923</DOCNO>
	<brief_summary>This randomise single-blind , placebo-controlled study investigate safety , tolerabilty , pharmacokinetics pharmacodynamics repeat ascend dos AZD2820 obese otherwise healthy male subject .</brief_summary>
	<brief_title>To Assess Safety , Tolerability , Pharmacokinetics Pharmakodynamics AZD2820 After Multiple Ascending Doses</brief_title>
	<detailed_description>A Phase I , Single Centre , Single-blind , Randomised , Placebo-controlled , Parallel-group Study Assess Safety , Tolerability , Pharmacokinetics , Pharmacodynamics AZD2820 Administration Multiple Ascending Doses .</detailed_description>
	<criteria>Provision sign date , write informed consent prior study specific procedure include genetic sampling analysis Obese otherwise healthy male subject age 18 45 year suitable vein cannulation repeat venepuncture Male subject willing use barrier contraception ie , condom , first day dose 3 month last dose investigational product Have body mass index ( BMI ) 27 40 kg/m2 History clinically significant disease disorder , opinion investigator , may either put subject risk participation study , influence result subject 's ability participate stud A history erectile dysfunction anatomic abnormality penis ( eg , cavernosal fibrosis , Peyronie 's disease , plaque ) interfere normal erectile function Prolonged QTcF &gt; 450 m shorten QTcF &lt; 340 m family history long QT syndrome History severe allergy/hypersensitivity ongoing allergy/hypersensitivity , judge investigator history hypersensitivity drug similar chemical structure class AZD2820 Any clinically significant abnormality clinical chemistry , haematology ( include eosinophilia ) urinalysis result judge investigator</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>obese</keyword>
	<keyword>healthy male volunteer</keyword>
	<keyword>multiple dos</keyword>
	<keyword>dose escalation</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>pharmakodynamics</keyword>
</DOC>